Real-time enrollment status for this advanced urothelial cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:00 AM UTC
| NCT Number | NCT07484022 |
| Recruiting Status | Recruiting |
| Condition | Advanced Urothelial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 37 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Generate Biomedicines |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07484022 is currently recruiting participants. This clinical trial study for advanced urothelial cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Generate Biomedicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07484022 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07484022 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.